1-(carboxymethylthio)tetradecane has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berge, RK; Bhurruth-Alcor, Y; Bohov, P; Dyrøy, E; Guisado, C; Jorgensen, MR; Kostarelos, K; Miller, AD; Müller, M; Røst, T; Skorve, J | 1 |
| Berge, K; Berge, RK; Gudbrandsen, OA; Rost, TH; Skorve, J; Tronstad, KJ; Wergedahl, H | 1 |
1 review(s) available for 1-(carboxymethylthio)tetradecane and Metabolic Syndrome
| Article | Year |
|---|---|
The metabolic syndrome and the hepatic fatty acid drainage hypothesis.
Topics: Animals; Fatty Acids; Fatty Acids, Nonesterified; Humans; Liver; Metabolic Syndrome; Mitochondria, Liver; Obesity; Oxidation-Reduction; PPAR alpha; Signal Transduction; Sulfides; Triglycerides | 2005 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Metabolic Syndrome
| Article | Year |
|---|---|
Synthesis and analysis of novel glycerolipids for the treatment of metabolic syndrome.
Topics: Animals; Glycerides; Glycerol; Male; Metabolic Syndrome; Peroxisome Proliferator-Activated Receptors; Phosphatidylcholines; Rats; Rats, Wistar; Sulfides | 2009 |